METiS Therapeutics

METiS Therapeutics is a privately held company located in Cambridge, Massachusetts. The company employs 34 individuals and generates approximately $2.5 million in annual revenue. METiS Therapeutics specializes in the development and application of its proprietary AI-powered platform, AiTEM, within the field of drug discovery and development. This platform leverages advanced algorithms, quantum mechanics, and molecular dynamics simulations to predict and analyze the properties of pharmaceutical ingredients. Their expertise extends to elucidating interactions between active pharmaceutical ingredients (APIs), targets, and excipients, as well as predicting chemical, physical, and pharmacokinetic properties of various therapeutic modalities in specific microenvironments. The company's unique platform enables efficient optimization of drug candidates, facilitates informed selection of promising leads, and supports the development of optimal formulations. Founded by a team possessing expertise in AI, entrepreneurship, and the biotechnology industry, METiS Therapeutics focuses on acquiring and licensing innovative assets that hold significant therapeutic potential and can benefit from its sophisticated data-driven approach. Companies seeking to accelerate drug discovery and optimize their development pipelines can explore partnership opportunities with METiS Therapeutics through their website at metistx.com.